LIPAC Oncology is a clinical-stage drug delivery company focused on developing unique localized therapies to treat cancer in challenging parts of the body. It’s breakthrough technology addresses shortcomings of current treatments for Bladder Cancer, Upper Tract Urothelial Carcinoma and Stage II/III Ovarian Cancer.